Semaglutide, a GLP-1 receptor agonist, is one of the innovative medications we offer to help our clients achieve their weight loss goals safely and sustainably
In todays fast-paced world, stress is more common than everand unfortunately, it can have a direct impact on our waistlines
Filing method-of-use patents tied to specific patient subpopulations, biomarker-defined indications, or combination regimens creates a layered IP estate that complicates any Paragraph IV challenge and preserves PBM negotiating leverage throughout the exclusivity lifecycle
The role of your healthcare provider This guide provides comprehensive information, but it does not replace medical advice
Increased GLP-1 adoption may weigh on discretionary food categories while supporting shifts in consumer behavior, including more spending on fitness and higher-quality dining experiences